Project Number AFTD-Rothstein-2013 Agency/Funding Organization The Association for Frontotemporal Degeneration Funding Year 2013 View Full Project Details for FTD C9ORF72 Based Biomarkers for Antisense-based Drug Discovery Validation Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers e. Multi-fluid Biomarkers Researcher and Organization Principal Investigator Rothstein, Jeffrey Principal Investigator First Name Jeffrey Principal Investigator Last Name Rothstein Awardee Organization JOHNS HOPKINS UNIVERSITY Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement Accelerating Drug Discovery for Frontotemporal Degeneration 2013 RFP FY Overall Cost $150,168 Funding Organization Agency/Funding Organization The Association for Frontotemporal Degeneration Funding Organization Country United States Program Official Nadine Tatton (AFTD)/Lauren Friedman (ADDF) Special Initiative Accelerating Drug Discovery for Frontotemporal Degeneration - AFTD Accelerating Drug Discovery for Frontotemporal Dementia - ADDF
